FDA Adverse Event Injury Summary report: N

6F ANGIO-SEAL VASCULAR CLOSURE DEVICE VIP

MDR report key: 1884065 · Received October 20, 2010

Report

Report Number
2182269-2010-00191
Event Type
Injury
Date Received
October 20, 2010
Report Date
October 20, 2010
Manufacturer
ST. JUDE MEDICAL
Product Code
MGB
PMA / PMN Number
P930038
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

NO PRODUCT WAS RETURNED. REVIEW OF THE DEVICE HISTORY RECORD WAS NOT POSSIBLE SINCE THE LOT NUMBER WAS UNAVAILABLE. BASED ON THE INFO RECEIVED, THE CAUSE FOR THE REPORTED EVENT COULD NOT BE CONCLUSIVELY DETERMINED; HOWEVER, THE PHYSICIAN STATED THAT THE PT'S ARTERY WAS LESS THAN 4 MM IN DIAMETER. THE ANGIO-SEAL DEVICE INSTRUCTIONS FOR USE (IFU) PRECAUTION THE USE OF THE ANGIO-SEAL IN PEDIATRIC PTS OR OTHERS WITH SMALL FEMORAL ARTERY SIZE (<4 MM IN DIAMETER). SMALL FEMORAL ARTERY SIZE MAY PREVENT THE ANGIO-SEAL ANCHOR FROM DEPLOYING PROPERLY IN THESE PTS. THE IFU ALSO STATES SHOULD ISCHEMIC SYMPTOMS APPEAR, TREATMENT OPTIONS INCLUDE THROMBOLYSIS, PERCUTANEOUS EXTRACTION OF THE ANCHOR OR FRAGMENTS, OR SURGICAL INTERVENTION.

Description of Event or Problem · 1

IT WAS REPORTED THAT A 6F ANGIO-SEAL VIP WAS DEPLOYED IN THE COMMON FEMORAL ARTERY (CFA) WITHOUT ANY DIFFICULTIES. THE PHYSICIAN STATED THAT THE ARTERY WAS SMALLER THAN 4 MM. AFTER ONE HOUR, THE PT COMPLAINED OF LEG PAIN AND SYMPTOMS OF VESSEL OCCLUSION. THE PT UNDERWENT SURGICAL INTERVENTION WHERE IT WAS DIAGNOSED THAT THE VESSEL OCCLUSION WAS AT THE SITE OF ANGIO-SEAL PLACEMENT. THE PT WAS REPORTED TO BE FINE FOLLOWING SURGERY. THE PHYSICIAN STATED THE EVENT WAS CAUSED BY PLACING THE ANGIO-SEAL IN A VESSEL DIAMETER SMALLER THAN 4 MM. THE EVENT DATE, IMPLANT DATE, EXPLANT DATE, AND LOT NUMBER WERE UNK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 6F ANGIO-SEAL VASCULAR CLOSURE DEVICE VIP ANGIO-SEAL VIP MGB ST. JUDE MEDICAL NA UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Hospitalization| R